BL 343AC

Drug Profile

BL 343AC

Latest Information Update: 21 Jun 1996

Price : $50

At a glance

  • Originator Slovak Academy of Sciences
  • Class Antihypertensives; Cardiotonics
  • Mechanism of Action Beta 1 adrenergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Arrhythmias

Most Recent Events

  • 21 Jun 1996 A pharmacodynamic study has been added to the Arrhythmias pharmacodynamics section
  • 02 May 1996 No-Development-Reported for Arrhythmias in Slovakia (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top